When is referral to an NCCN-designated center indicated for the treatment of soft tissue sarcoma?

Updated: Apr 29, 2019
  • Author: from Memorial Sloan-Kettering - Mrinal M Gounder, MD; Chief Editor: Edwin Choy, MD, PhD  more...
  • Print
Answer

Answer

When possible, patients should be referred to an NCCN-designated center and enrolled in clinical trials.


Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!